Editorial
doi: 10.1016/s0022-5347(01)65704-5.
Significant versus insignificant prostate cancer--can we identify the tigers from the pussy cats?
- PMID: 8709309
- DOI: 10.1016/s0022-5347(01)65704-5
Item in Clipboard
Editorial
Significant versus insignificant prostate cancer--can we identify the tigers from the pussy cats?
J Urol.
1996 Sep.
No abstract available
Comment on
-
Pathological characteristics and prognosis of nonpalpable and palpable prostate cancers with a Hybritech prostate specific antigen of 4 to 10 ng./ml.J Urol. 1996 Sep;156(3):1056-8. J Urol. 1996. PMID: 8709306
-
Distinguishing clinically important from unimportant prostate cancers before treatment: value of systematic biopsies.J Urol. 1996 Sep;156(3):1059-63. J Urol. 1996. PMID: 8709307
-
Ki-67 expression is a prognostic marker of prostate cancer recurrence after radical prostatectomy.J Urol. 1996 Sep;156(3):1064-8. J Urol. 1996. PMID: 8709308
Similar articles
-
Transrectal ultrasound and prostate-specific antigen in prostate cancer.J Med Imaging Radiat Oncol. 2008 Oct;52(5):530. doi: 10.1111/j.1440-1673.2008.02009.x. J Med Imaging Radiat Oncol. 2008. PMID: 19032406 No abstract available.
-
Breast metastasis from prostate cancer and interpretation of immunoreactivity to prostate-specific antigen.Int J Urol. 2006 Apr;13(4):463-5. doi: 10.1111/j.1442-2042.2006.01327.x. Int J Urol. 2006. PMID: 16734876
-
Prediction of pathological outcomes for a single microfocal (≤3 mm) Gleason 6 prostate cancer detected via contemporary multicore (≥12) biopsy in men with prostate-specific antigen ≤10 ng/mL.BJU Int. 2011 Oct;108(7):1101-5. doi: 10.1111/j.1464-410X.2010.09996.x. Epub 2010 Dec 24. BJU Int. 2011. PMID: 21199287
-
Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings.J Urol. 1998 Dec;160(6 Pt 2):2407-11. J Urol. 1998. PMID: 9817393 Review.
-
Prevalence and characteristics of screen-detected prostate carcinomas at low prostate-specific antigen levels: aggressive or insignificant?BJU Int. 2005 Feb;95(2):231-7. doi: 10.1111/j.1464-410X.2005.05324.x. BJU Int. 2005. PMID: 15667646 Review.
Cited by
-
Decision models for distinguishing between clinically insignificant and significant tumors in prostate cancer biopsies: an application of Bayes' Theorem to reduce costs and improve outcomes.Health Care Manag Sci. 2020 Mar;23(1):102-116. doi: 10.1007/s10729-019-09480-6. Epub 2019 Mar 18. Health Care Manag Sci. 2020. PMID: 30880374
-
Incidence of prostate cancer in Eritrea: Data from the National Health Laboratory, Orotta Referral Hospital and Sembel Hospital 2011-2018.PLoS One. 2020 Apr 23;15(4):e0232091. doi: 10.1371/journal.pone.0232091. eCollection 2020. PLoS One. 2020. PMID: 32324838 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous